ciprofloxacin has been researched along with fluconazole in 150 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (6.00) | 18.2507 |
| 2000's | 24 (16.00) | 29.6817 |
| 2010's | 103 (68.67) | 24.3611 |
| 2020's | 14 (9.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cortijo, J; Gálvez, J; García-Domenech, R; Morcillo, E; Ríos-Santamarina, I; Santamaria, P | 1 |
| Malan, SF; Swart, H; Van Dyk, S | 1 |
| Balakin, KV; Ivachtchenko, AV; Kazmirchuk, VV; Kovalenko, SM; Zhuravel', IO | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Holla, BS; Karthikeyan, MS; Kumari, NS | 1 |
| Erdoğan, T; Göker, H; Güven, OO; Yildiz, S | 1 |
| Adamec, J; Beckert, R; Buchta, V; Kaustová, J; Klimesová, V; Möllmann, U; Waisser, K; Weiss, D | 1 |
| Bhattacharjee, G; Kumar, A; Tomar, V | 1 |
| Judge, V; Narang, R; Narasimhan, B; Ohlan, R; Ohlan, S | 2 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Pandey, SK; Singh, A | 1 |
| Jalbout, A; Kumar, P; Narasimhan, B; Sharma, D | 1 |
| Altanlar, N; Kiper, T; Tunçbilek, M | 1 |
| Bhatia, RK; Gupta, V; Ishar, MP; Raj, T; Sharma, D; Sharma, RK | 1 |
| Agrawal, SS; Minu, M; Narasimhan, B; Thangadurai, A; Wakode, SR | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Hosamani, KM; Keri, RS; Shingalapur, RV | 1 |
| Chandrashekar, SM; Mallikarjuna, BP; Rajendraprasad, Y; Sastry, BS; Sathisha, K; Suresh Kumar, GV | 1 |
| Bansode, TN; Dongre, VG; Shelke, JV | 1 |
| Bharti, SK; Nath, G; Singh, SK; Tilak, R | 1 |
| Gopalakrishnan, M; Kanagarajan, V; Thanusu, J | 2 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Basanagouda, M; Kulkarni, MV; Mohite, AA; Mutha, SS; Patel, H; Rasal, VP; Shivashankar, K | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chandrashekar, SM; Kistayya, C; Mallikarjuna, BP; Rajendraprasad, Y; Suresh Kumar, GV | 1 |
| Balzarini, J; De Clercq, E; Judge, V; Kumar, D; Narang, R; Narasimhan, B; Sangwan, S | 1 |
| Bhandari, A; Ranawat, MS; Sharma, R; Sharma, S; Soni, B | 1 |
| Abd El-Moez, SI; Abotaleb, N; Ahmed, MF; Kamel, MM; Kassem, EM; Mohamed, MS | 1 |
| Aneja, KR; Kumar, M; Kumar, R; Prakash, O; Sharma, C | 1 |
| Chandrashekar, SM; Mallikarjuna, BP; Rajendra Prasad, Y; Suresh Kumar, GV | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Aneja, KR; Chandak, N; Kumar, P; Sharma, C; Sharma, PK | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Ahmad, A; Khan, AU; Musthafa, TN; Siddiqui, ZN | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Aneja, DK; Aneja, KR; Arora, S; Hussain, K; Lohan, P; Prakash, O; Ranjan, P; Sharma, C | 1 |
| Fronczek, FR; Indumathi, T; Jamal Ahamed, VS; Moon, SS; Rajendra Prasad, KJ | 1 |
| Ahsan, MJ; Gaur, R; Khalilullah, H; Nomani, MS; Samy, JG; Saraswat, P; Singh, A | 1 |
| Arun, Y; Balachandran, C; Bhaskar, G; Perumal, PT; Saikumar, C | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ; Teraiya, SB | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
| Agarwal, DD; Gupta, SK; Sahu, PK; Thavaselvam, D | 1 |
| Chovatia, PT; Parekh, HH; Pathak, RB | 1 |
| Garudachari, B; Hegde, G; Isloor, AM; Satyanarayana, MN; Shivakumar, CK; Shivananda, KN; Thippeswamy, B | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Bobade, VD; Mhaske, PC; Nandave, M; Narkhade, S; Shelke, SH; Walhekar, NM | 1 |
| Hamid, A; Jaglan, S; Klapötke, TM; Kumar, D; Narasimhan, B; Qazi, AK; Singh, K; Stierstorfer, J; Verma, V | 1 |
| Ishar, MP; Kaur, H; Saxena, AK; Sharma, V; Singh, G | 1 |
| Ahsan, MJ; Govindasamy, J; Khalilullah, H; Mohan, G; Stables, JP | 1 |
| Cieslik, W; Jampilek, J; Machura, B; Musiol, R; Nycz, JE; Polanski, J; Vejsova, M; Wolff, M | 1 |
| Darandale, SN; Mulla, NA; Pansare, DN; Shinde, DB | 1 |
| Agarwal, A; Awasthi, SK; Nath, G; Singh, MK; Tilak, R | 1 |
| Agarwal, DD; Gupta, SK; Lal, J; Thavaselvam, D | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fun, HK; Garudachari, B; Isloor, AM; Kulal, A; Pavithra, N; Satyanarayana, MN | 1 |
| Chanu, MB; Mahendra, M; Puttaraju, KB; Rai, K; Rasal, VP; Shivashankar, K; Venkata Vivek, PN | 1 |
| Ishar, MP; Raj, T; Singh, N | 1 |
| Ablordeppey, SY; Boateng, C; Bolden, S; Etukala, JR; Flores-Rozas, H; Jacob, MR; Khan, SI; Mazu, T; Walker, LA; Zhu, XY | 1 |
| Joshi, SD; Kulkarni, MV; More, UA; Revankar, HM | 1 |
| Ahmad, A; Khan, AU; Rauf, A; Rehan, M; Subbarao, N; Varshney, H | 1 |
| Gade, WN; Khan, FA; Marathe, SD; Patil, RH; Sangshetti, JN; Shaikh, RI; Shinde, DB | 1 |
| Soman, SS; Soni, JN | 1 |
| Harikrishna, N; Kotaiah, Y; Nagaraju, K; Venkata Rao, C; Vijjulatha, M; Yamini, L | 1 |
| Andes, DR; Cmoch, P; Edward, JA; Jaromin, A; Kaczmarek, Ł; Kozubek, A; Peczyńska-Czoch, W; Sidoryk, K; Stefańska, J; Świtalska, M; Szczepek, W; Wietrzyk, J; Zagrodzka, J; Zarnowski, R | 1 |
| Mulla, NA; Pansare, DN; Pawar, CD; Shende, VR; Shinde, DB | 1 |
| Mishra, NN; Prabhakar, YS; Saquib, M; Sharma, S; Shaw, AK; Shukla, PK; Srivastava, R; Verma, S | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Alam, MS; Bano, S; Das, AK; Dhulap, A; Dudeja, M; Javed, K | 1 |
| Geng, RX; Kumar, KV; Zhang, L; Zhou, CH | 1 |
| Kariyappa, AK; Nagamallu, R; Ningappa, MB; Srinivasan, B | 1 |
| Jiang, M; Li, S; Li, Z; Wang, H; Yuan, H | 1 |
| Addla, D; Cai, GX; Geng, RX; Li, S; Ponmani, J; Wang, A; Wang, YN; Xie, D; Zhang, L; Zhang, SL; Zhou, CH | 1 |
| Agarwal, A; Agarwal, D; Awasthi, SK; Gupta, RD; Kant, R; Kumar, D; Tilak, R | 1 |
| Khan, FA; Lohar, KS; Patil, RH; Sangshetti, JN; Zaheer, Z | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Günal, S; Kaloğlu, M; Kaloğlu, N; Özdemir, İ | 1 |
| Chandrasekaran, B; Cherukupalli, S; Hampannavar, GA; Karpoormath, R; Palakollu, VN; Thapliyal, N | 1 |
| Kulkarni, MR; Lad, NP; Manohar, Y; Mascarenhas, M; Pandit, SS; Pandit, YB; Salkar, K; Sharma, R; Suthar, A | 1 |
| Kashaw, SK; Kashaw, V; Mishra, M; Mishra, VK | 1 |
| Dalkara, S; Doğan, İS; Eşsiz Gökhan, Ş; Kart, D; Saraç, S; Sari, S; Vural, İ | 1 |
| Desai, S; Desai, V; Dixit, SK; Gaonkar, SN; Joshi, SD; Palyekar, U | 1 |
| Jacob, MR; Jain, R; Khan, SI; Kumar, V; Maurya, IK; Sharma, KK; Tikoo, K | 1 |
| Chou, S; Dou, X; Shan, A; Song, J; Wang, J; Wang, Z; Yang, Y; Yang, Z | 1 |
| Chen, S; He, S; Liu, X; Qiu, G; Shi, J; Tang, W; Wu, X; Xu, K; Zhang, J | 1 |
| Kumar, A; Kumar, L; Kumar, R; Lal, K; Paul, AK; Yadav, P | 1 |
| Ashok, D; Goud, GL; Manga, V; Ramesh, S; Reddy, VP; Saikrishna, B; Sriram, D; Yogeeswari, P | 1 |
| Alkahtani, HM; Almehizia, AA; Ansari, SA; Kaduskar, RN; Khan, FAK; Patil, R; Patil, RH; Sangshetti, JN; Shinde, DB | 1 |
| Dang, LH; Dung, TT; Hai, DS; Kim Van, HT; Ky Duyen, NT; Mai, NT; Ngoc Bich, VT; Thanh Van, TT; Thanh, ND; Thu Hien, PT; Toan, DN; Toan, VN | 1 |
| Abdel-Hamid, H; Abu-Serie, MM; Noby, A; Ramadan, ES; Salah Ayoup, M; Teleb, M; Wahby, Y | 1 |
| Zhang, B | 1 |
| Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
| Ba, Y; Wang, S; Xu, Z; Zhang, J | 1 |
| Ba, Y; Hou, X; Wang, S; Xu, Z; Yang, H; Zhang, J | 1 |
| Ali, Z; Bae, JY; Chittiboyina, AG; Khan, IA; Viljoen, AM; Wang, YH; Zaki, AA | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Liu, H; Long, S; Rakesh, KP; Zha, GF | 1 |
| Augustynowicz-Kopeć, E; Bojanowski, K; Foks, H; Gobis, K; Głogowska, A; Korona-Głowniak, I; Krause, M; Siluk, D; Ziembicka, D | 1 |
| Dixit, PP; Haval, KP; Haval, NB; Kasare, SL; Khedkar, VM; Patil, PS; Rekha, EM; Sriram, D | 1 |
| Bakale, RD; Dhumal, ST; Dixit, PP; Haval, KP; Khedkar, VM; Krishna, VS; Kulkarni, RS; Phatak, PS; Sriram, D | 1 |
| Dinh Thanh, N; Minh Tri, N; Ngoc Toan, V; Thi Thu Huong, N | 1 |
| Bayannavar, PK; Hoolageri, SR; Joshi, SD; Kamble, RR; Kodasi, B; Kumbar, VM; Nesaragi, AR; Shaikh, SKJ | 1 |
| Fang, B; Fawad Ansari, M; Li, D; Li, FF; Tan, YM; Zhou, CH | 1 |
| Broughton, BJ | 1 |
| Bause, H; Höver, S; Scholz, J; Schulz, M; Steinfath, M | 1 |
| Li, X; Xie, W | 1 |
| Dekker, AW; Rozenberg-Arska, M; Verdonck, LF | 1 |
| Holmgren, D; Horowitz, HW; Seiter, K | 1 |
| Elewski, BE | 1 |
| Chen, RJ; Liu, XP; Sugar, AM | 1 |
| de Marie, S; Kluytmans, JA; Nouwen, JL; Sluijs, J; van Belkum, A; Verbrugh, HA; Wielenga, JJ | 1 |
| Beelen, DW; Dermoumi, H; Elmaagacli, A; Heintschel von Heinegg, E; Müller, KD; Peceny, R; Runde, V; Schaefer, UW; Trenschel, R | 1 |
| Engervall, P; Persson, L; Sjöberg, L; Tidefelt, U; Vikerfors, T | 1 |
| Choi, JH; Choi, SM; Kim, CC; Kim, DW; Kim, HJ; Kim, YJ; Lee, DG; Lee, JW; Lee, S; Min, CK; Min, WS; Park, YH; Shin, WS; Yoo, JH | 1 |
| Arora, R; Batra, S; Malhotra, M; Sharma, JB; Sharma, S | 1 |
| Allotey, J; Duncan, H; Williams, H | 1 |
| Best, L; Boonlayangoor, S; Hebert, C; Lin, M; Pitrak, D; Tolentino, J; Villaran, R; Weber, SG | 1 |
| Kekulé, AS; Kreft, B; Lübbert, C; Marsch, WC; Oehme, A | 1 |
| Arias Rodríguez, M; Palomar Fontanet, R; Quintela Obregón, E; Rodrigo Calabia, E; Salas, C | 1 |
| Kumar, P; Narasimhan, B; Sharma, D; Sriram, D; Yogeeswari, P | 1 |
| Barshikar, S; Baylor, AE; Dolman, HS; Glowniak, J; Hong, K; Lavery, T; Nailor, M; Singla, R; Stassinopoulus, J; Tyburski, JG; Wilson, RF; Zimmerman, LH | 1 |
| Huh, J; Kang, EH; Kim, S; Kim, SH; Lee, DH; Lee, K; Park, JS; Sohn, BS; Suh, C; Yoon, DH | 1 |
| Ammori, BJ; Ashcroft, DM; Darwich, AS; Jamei, M; Pade, D; Rostami-Hodjegan, A | 1 |
| Bonati, M; Choonara, I; Jacqz-Aigrain, E; Kaguelidou, F; Manzoni, P; Pandolfini, C; Sequi, M; Turner, MA | 1 |
| Marco, S; Maurizio, B; Pandolfini, C; Paolo, M | 1 |
| Blennow, O; Ljungman, P; Mattsson, J; Remberger, M; Sparrelid, E | 1 |
| Adil, SN; Ali, N; Shaikh, MU | 1 |
| Gribakina, OG; Kolyvanov, GB; Novitskaia, IaG; Seredenin, SB; Smirnov, VV; Zherdev, VP | 1 |
| Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S | 1 |
| Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC | 1 |
| Bergami, E; Cavanna, C; Decembrino, N; Introzzi, F; Lallitto, F; Mangione, F; Marone, P; Tamarozzi, F; Tortorano, AM; Zecca, M | 1 |
| Mascarenhas, J; Pradhan, S; Uddaraju, M | 1 |
| Jandaik, S; Kumar, S; Sharma, N | 1 |
| Burns, MJ; Kesler, KA; Langdorf, MI | 1 |
| Butcher, J; Hansom, D; Kean, R; Mackay, WG; Ramage, G; Sherry, L; Townsend, EM; Williams, C | 1 |
| Daali, Y; Desmeules, JA; Marsousi, N; Rudaz, S | 1 |
| Becker, ML; Berger, FA; Broers, AEC; de Groot, NMS; Monadian, N; Santbergen, B; van den Bemt, PMLA; van der Sijs, H; van Gelder, T | 1 |
| Bhat, MA; Bhat, ZS; Lone, AM; Prakash, P; Rather, MA; Tantry, IQ | 1 |
| Agarwal, M; Gandhi, A; Mayor, R; Paul, L; Shrivastav, A; Singh, S | 1 |
| Jandhyala, D; Sohail, MR; Stahr, DC; Tan, EM | 1 |
| Dȩbowski, D; Gitlin-Domagalska, A; Gucwa, K; Milewski, S; Okońska, J; Olkiewicz, K; Ptaszyńska, N; Rolka, K; Ruczyński, J; Łȩgowska, A | 1 |
| Bodin, A; Fejes, I; Garcia-Hermosa, P | 1 |
| Goto, K; Itoh, H; Kai, M; Kitano, T; Ohchi, Y; Suzuki, Y; Tanaka, R; Tatsuta, R; Yasuda, N | 1 |
| Bachmann, F; Duthaler, U; Krähenbühl, S; Meyer Zu Schwabedissen, HE | 1 |
| Achachi, N; Matmour, D; Toumi, H | 1 |
| Allen, L; Bartash, R; Cowman, K; Fauvel, D; Guo, Y; Minamoto, GY; Nnani, DU; Patel, S; Vukelic, S | 1 |
| Alffenaar, JC; da Silva Ferreira, AR; Harmsen, HJM; Junier, LAT; Liu, L; Märtson, AG; Span, LF; Sturkenboom, MGG; Tissing, WJE; van der Werf, TS; Veringa, A; Wardill, HR | 1 |
| Brüggemann, RJM; Gompelman, M; Jager, NGL; Korzilius, JW; Rovers, CP; Wanten, GJA; Wezendonk, GTJ | 1 |
9 review(s) available for ciprofloxacin and fluconazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
Topics: Animals; Chemistry Techniques, Synthetic; Humans; Pyrazoles; Pyrimidines | 2017 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents.
Topics: Anti-Bacterial Agents; Bacteria; Chelating Agents; Fungi; Microbial Sensitivity Tests; Molecular Structure; Quinolones; Structure-Activity Relationship; Triazoles | 2019 |
Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
Topics: Anti-Bacterial Agents; Bacterial Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroimidazoles | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents.
Topics: Anti-Bacterial Agents; Antiviral Agents; Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Triazines; Viruses | 2020 |
Keratitis Caused by Candida parapsilosis and Subsequent Corynebacterium macginleyi Infection: Case Report and Short Review.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candida parapsilosis; Candidiasis; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Eye Infections, Bacterial; Eye Infections, Fungal; Fluconazole; Humans; Keratitis; Male | 2020 |
6 trial(s) available for ciprofloxacin and fluconazole
| Article | Year |
|---|---|
Infection prevention in autologous bone marrow transplantation and the role of protective isolation.
Topics: Adolescent; Adult; Amphotericin B; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Patient Isolation; Prospective Studies; Transplantation, Autologous | 1994 |
Stepdown single agent antibiotic therapy for the management of the high risk neutropenic adult with hematologic malignancies.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Fluconazole; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 1996 |
Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Bacteria, Anaerobic; Bone Marrow Transplantation; Candidiasis; Cause of Death; Ciprofloxacin; Disease Susceptibility; Female; Fluconazole; Fungemia; Fungi; Hematologic Neoplasms; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; Intestinal Diseases; Intestines; Male; Metronidazole; Middle Aged; Mycoses; Neuroaspergillosis; Opportunistic Infections; Premedication; Prospective Studies; Superinfection; Transplantation Conditioning; Treatment Outcome | 2000 |
Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Fluconazole; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Prospective Studies; Roxithromycin; Treatment Outcome | 2002 |
Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial.
Topics: Adolescent; Adult; Azithromycin; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Pelvic Inflammatory Disease; Prospective Studies; Tinidazole | 2003 |
Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4-methylaminoantipyrine.
Topics: Ciprofloxacin; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Dipyrone; Fluconazole; Humans; Male | 2022 |
135 other study(ies) available for ciprofloxacin and fluconazole
| Article | Year |
|---|---|
New bronchodilators selected by molecular topology.
Topics: Animals; Bronchodilator Agents; Discriminant Analysis; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Structure-Activity Relationship; Trachea | 1998 |
The activity of p-methoxybenzylisothiocyanate against Neisseria gonorrhoeae, Haemophilus ducreyi, and other microorganisms.
Topics: Bacteria; Cell Division; Haemophilus ducreyi; Isothiocyanates; Lepidium; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Plant Preparations | 2002 |
Synthesis and antimicrobial activity of 5-hydroxymethyl- 8-methyl-2-(N-arylimino)-pyrano[2,3-c]pyridine-3-(N-aryl)-carboxamides.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Candida albicans; Ciprofloxacin; Fluconazole; Microbial Sensitivity Tests; Pyridines; Structure-Activity Relationship | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis and antimicrobial studies on novel chloro-fluorine containing hydroxy pyrazolines.
Topics: Anti-Bacterial Agents; Antifungal Agents; Chalcones; Colony Count, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Mitosporic Fungi; Pyrazoles; Structure-Activity Relationship | 2007 |
Synthesis and antimicrobial activity of some novel phenyl and benzimidazole substituted benzyl ethers.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Benzimidazoles; Benzyl Compounds; Drug Resistance, Bacterial; Ethers; Methicillin; Microbial Sensitivity Tests; Phenols; Staphylococcus aureus | 2007 |
Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antitubercular Agents; Bacteria; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, Thin Layer; Estrone; Fungi; Heterocyclic Compounds; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared | 2007 |
Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Benzaldehydes; Candida; Candida albicans; Chalcones; Ciprofloxacin; Escherichia coli; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Piperazines; Staphylococcus aureus; Structure-Activity Relationship; Thiophenes | 2007 |
Quantitative structure-activity relationship studies for prediction of antimicrobial activity of synthesized 2,4-hexadienoic acid derivatives.
Topics: Anti-Infective Agents; Hexanones; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Hansch analysis of veratric acid derivatives as antimicrobial agents.
Topics: Anti-Infective Agents; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Structure-Activity Relationship; Vanillic Acid | 2009 |
Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]-triazine and [1,2,4,5]-tetrazine rings.
Topics: Anti-Infective Agents; Bacteria; Fungi; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Quinazolinones; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Triazines; Triazoles | 2009 |
Synthesis and QSAR evaluation of 2-(substituted phenyl)-1H-benzimidazoles and [2-(substituted phenyl)-benzimidazol-1-yl]-pyridin-3-yl-methanones.
Topics: Anti-Infective Agents; Bacteria; Benzimidazoles; Fungi; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship | 2009 |
Synthesis and in vitro antimicrobial activity of some novel substituted benzimidazole derivatives having potent activity against MRSA.
Topics: Anti-Infective Agents; Bacillus subtilis; Benzimidazoles; Candida albicans; Drug Evaluation, Preclinical; Escherichia coli; Magnetic Resonance Spectroscopy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization | 2009 |
Mechanism of unusual formation of 3-(5-phenyl-3H-[1,2,4]dithiazol-3-yl)chromen-4-ones and 4-oxo-4H-chromene-3-carbothioic acid N-phenylamides and their antimicrobial evaluation.
Topics: Amides; Anti-Infective Agents; Bacteria; Chromones; Crystallography, X-Ray; Fungi; Microbial Sensitivity Tests; Spectrum Analysis; Structure-Activity Relationship | 2009 |
Synthesis, antimicrobial activity and QSAR studies of new 2,3-disubstituted-3,3a,4,5,6,7-hexahydro-2H-indazoles.
Topics: Algorithms; Anti-Bacterial Agents; Antifungal Agents; Indazoles; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Bacteria; Benzimidazoles; Fungi; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship | 2009 |
Synthesis of new 4-isopropylthiazole hydrazide analogs and some derived clubbed triazole, oxadiazole ring systems--a novel class of potential antibacterial, antifungal and antitubercular agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Bacteria; Cell Line, Tumor; Cell Survival; Fungi; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles | 2009 |
Synthesis and antimicrobial activity of some new N-acyl substituted phenothiazines.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Imides; Microbial Sensitivity Tests; Molecular Structure; Phenothiazines | 2009 |
Synthesis, anti-bacterial and anti-fungal activities of some novel Schiff bases containing 2,4-disubstituted thiazole ring.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Microbial Sensitivity Tests; Thiazoles | 2010 |
Synthesis, spectral analysis and in vitro microbiological evaluation of 3-(3-alkyl-2,6-diarylpiperin-4-ylidene)-2-thioxoimidazolidin-4-ones as a new class of antibacterial and antifungal agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Imidazolidines; Microbial Sensitivity Tests; Piperidines; Thiohydantoins | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Synthesis and antimicrobial studies on novel sulfonamides containing 4-azidomethyl coumarin.
Topics: Anti-Bacterial Agents; Antifungal Agents; Azides; Bacteria; Coumarins; Fungi; Microbial Sensitivity Tests; Molecular Structure; Sulfonamides | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Synthesis and in vitro microbiological evaluation of an array of biolabile 2-morpholino-N-(4,6-diarylpyrimidin-2-yl)acetamides.
Topics: Acetamides; Anti-Infective Agents; Bacteria; Fungi; Microbial Sensitivity Tests; Morpholines; Pyrimidines; Spectrophotometry, Infrared | 2010 |
Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Antitubercular Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Triazoles | 2010 |
Benzylidene/2-chlorobenzylidene hydrazides: synthesis, antimicrobial activity, QSAR studies and antiviral evaluation.
Topics: Anti-Infective Agents; Antiviral Agents; Bacteria; Benzylidene Compounds; Fungi; HeLa Cells; Humans; Hydrazines; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Viruses | 2010 |
Synthesis and evaluation of some new benzothiazole derivatives as potential antimicrobial agents.
Topics: Anti-Infective Agents; Azo Compounds; Bacteria; Benzothiazoles; Fungi; Thiosemicarbazones | 2010 |
Novel 6,8-dibromo-4(3H)quinazolinone derivatives of anti-bacterial and anti-fungal activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Drug Design; Drug-Related Side Effects and Adverse Reactions; Fungi; Microbial Sensitivity Tests; Quinazolinones | 2010 |
Hypervalent iodine(III) mediated synthesis of novel unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles as antibacterial and antifungal agents.
Topics: Acetates; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Drug Discovery; Fungi; Hydrazones; Iodine; Methylene Chloride; Microbial Sensitivity Tests; Oxadiazoles; Oxidation-Reduction | 2010 |
Synthesis and pharmacological evaluation of clubbed isopropylthiazole derived triazolothiadiazoles, triazolothiadiazines and mannich bases as potential antimicrobial and antitubercular agents.
Topics: Anti-Infective Agents; Antitubercular Agents; Bacteria; Fungi; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Spectrophotometry, Infrared; Thiazoles | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Synthesis and biological evaluation of some 4-functionalized-pyrazoles as antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Benzenesulfonamides; Carboxylic Acids; Fungi; Microbial Sensitivity Tests; Pyrazoles; Sulfonamides | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Thermal solvent-free synthesis of novel pyrazolyl chalcones and pyrazolines as potential antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Chalcones; Fungi; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Solvents; Temperature | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis and biological evaluation of dihydroindeno and indeno [1,2-e] [1,2,4]triazolo [3,4-b] [1,3,4]thiadiazines as antimicrobial agents.
Topics: Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Fungi; Humans; Indans; Microbial Sensitivity Tests; Mycoses; Thiadiazines; Triazoles | 2011 |
L-Proline anchored multicomponent synthesis of novel pyrido[2,3-a]carbazoles; investigation of in vitro antimicrobial, antioxidant, cytotoxicity and structure activity relationship studies.
Topics: Anti-Infective Agents; Antineoplastic Agents; Bacteria; Carbazoles; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Design; Free Radical Scavengers; Fungi; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Proline; Structure-Activity Relationship | 2011 |
Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents.
Topics: Administration, Oral; Anti-Infective Agents; Antitubercular Agents; Bacteria; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Software; Structure-Activity Relationship | 2011 |
Synthesis of novel spirooxindole derivatives by one pot multicomponent reaction and their antimicrobial activity.
Topics: Anti-Infective Agents; Bacteria; Chemistry Techniques, Synthetic; Fungi; Indoles; Microbial Sensitivity Tests; Oxindoles | 2012 |
An efficient one-pot synthesis, structure, antimicrobial and antioxidant investigations of some novel quinolyldibenzo[b,e][1,4]diazepinones.
Topics: Anti-Infective Agents; Antioxidants; Azepines; Crystallography, X-Ray; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Quinolines | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
Synthesis and evaluation of antimicrobial activity of 4H-pyrimido[2,1-b]benzothiazole, pyrazole and benzylidene derivatives of curcumin.
Topics: Anti-Infective Agents; Bacteria; Benzothiazoles; Benzylidene Compounds; Cell Line, Tumor; Chemistry Techniques, Synthetic; Curcumin; Fungi; Humans; Microbial Sensitivity Tests; Pyrazoles; Structure-Activity Relationship | 2012 |
Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
Topics: Anti-Infective Agents; Antitubercular Agents; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazoles; Structure-Activity Relationship | 2012 |
Synthesis, characterization and antimicrobial studies of some new quinoline incorporated benzimidazole derivatives.
Topics: Anti-Infective Agents; Bacteria; Benzimidazoles; Chemistry Techniques, Synthetic; Fungi; Quinolines | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synthesis and pharmacological evaluation of a novel series of 3-aryl-2-(2-substituted-4-methylthiazole-5-yl)thiazolidin-4-one as possible anti-inflammatory and antimicrobial agents.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Bacteria; Bacterial Infections; Carrageenan; Edema; Fungi; Humans; Indomethacin; Microbial Sensitivity Tests; Mycoses; Rats; Thiazoles; Thiazolidines | 2012 |
Synthesis, antimicrobial and cytotoxicity study of 1,3-disubstituted-1H-naphtho[1,2-e][1,3]oxazines.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Candida albicans; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured | 2012 |
Synthesis of β-ionone derived chalcones as potent antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Chalcones; Fungi; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycoses; Norisoprenoids; Staphylococcal Infections | 2012 |
POMA analyses as new efficient bioinformatics' platform to predict and optimise bioactivity of synthesized 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.
Topics: Amides; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anticonvulsants; Antifungal Agents; Aspergillus niger; Bacillus subtilis; Candida albicans; Cell Line; Cell Survival; Computational Biology; Escherichia coli; HIV-1; HIV-2; Humans; Mice; Microbial Sensitivity Tests; Motor Activity; Pseudomonas aeruginosa; Pyrazoles; Staphylococcus aureus; Thioamides | 2012 |
Contribution to investigation of antimicrobial activity of styrylquinolines.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Hydrocarbons, Halogenated; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Structure-Activity Relationship | 2012 |
Green synthesis of tetrahydropyrimidine analogues and evaluation of their antimicrobial activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Aspergillus; Bacillus subtilis; Candida albicans; Catalysis; Escherichia coli; Green Chemistry Technology; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Zirconium | 2013 |
Design, synthesis and antimicrobial activity of novel benzothiazole analogs.
Topics: Anti-Bacterial Agents; Antifungal Agents; Benzothiazoles; Click Chemistry; Drug Design; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Humans; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure | 2013 |
Biological activity, design, synthesis and structure activity relationship of some novel derivatives of curcumin containing sulfonamides.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Bacteria; Cell Proliferation; Curcumin; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Fungi; HCT116 Cells; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design and regioselective synthesis of trifluoromethylquinolone derivatives as potent antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Candida albicans; Ciprofloxacin; Crystallography, X-Ray; Drug Design; Fluorine; Molecular Structure; Penicillium chrysogenum; Quinolines | 2013 |
Microwave assisted synthesis of dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones; synthesis, in vitro antimicrobial and anticancer activities of novel coumarin substituted dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Screening Assays, Antitumor; Fungi; Humans; Microbial Sensitivity Tests; Microwaves; Models, Molecular; Molecular Structure; Pyrimidinones | 2013 |
Unusual transformation of substituted-3-formylchromones to pyrimidine analogues: synthesis and antimicrobial activities of 5-(o-hydroxyaroyl)pyrimidines.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Chromones; Geotrichum; HeLa Cells; Humans; Microbial Sensitivity Tests; Pyrimidines; Structure-Activity Relationship | 2013 |
Structure-activity relationship (SAR) and preliminary mode of action studies of 3-substituted benzylthioquinolinium iodide as anti-opportunistic infection agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Biological Products; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Quinolinium Compounds; Structure-Activity Relationship; Vero Cells | 2013 |
Synthesis, biological evaluation and docking studies of 4-aryloxymethyl coumarins derived from substructures and degradation products of vancomycin.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Candida albicans; Coumarins; Enterococcus faecalis; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Novobiocin; Vancomycin | 2013 |
Designing and synthesis of novel antimicrobial heterocyclic analogs of fatty acids.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Candida; Cyclization; Dose-Response Relationship, Drug; Drug Design; Fatty Acids; Heterocyclic Compounds; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Software; Structure-Activity Relationship | 2013 |
Synthesis, antileishmanial activity and docking study of N'-substitutedbenzylidene-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetohydrazides.
Topics: Administration, Oral; Anti-Infective Agents; Antiprotozoal Agents; Benzylidene Compounds; Binding Sites; Drug Design; Half-Life; Hydrazines; Leishmania donovani; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxidoreductases; Protein Structure, Tertiary; Protozoan Proteins; Pyridines | 2014 |
Synthesis and antimicrobial evaluation of amide derivatives of benzodifuran-2-carboxylic acid.
Topics: Amides; Anti-Infective Agents; Bacterial Infections; Benzofurans; Candida albicans; Candidiasis; Carboxylic Acids; Cyclization; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests | 2014 |
Synthesis, docking and evaluation of antioxidant and antimicrobial activities of novel 1,2,4-triazolo[3,4-b][1,3,4]thiadiazol-6-yl)selenopheno[2,3-d]pyrimidines.
Topics: Anti-Infective Agents; Antioxidants; Bacteria; Bacterial Infections; Benzene Derivatives; Fungi; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycoses; Organoselenium Compounds; Pyrimidines; Thiadiazoles | 2014 |
Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities.
Topics: Alkaloids; Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; BALB 3T3 Cells; Biofilms; Candida albicans; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fibroblasts; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Structure-Activity Relationship | 2014 |
One pot three components microwave assisted and conventional synthesis of new 3-(4-chloro-2-hydroxyphenyl)-2-(substituted) thiazolidin-4-one as antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus flavus; Aspergillus niger; Candida albicans; Dose-Response Relationship, Drug; HeLa Cells; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Thiazolidines | 2014 |
Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Carbohydrates; Catalytic Domain; Cell Line; Chemistry Techniques, Synthetic; Click Chemistry; Drug Design; Fungi; Microbial Sensitivity Tests; Models, Molecular; Penicillin-Binding Proteins; Triazoles | 2014 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Synthesis, biological evaluation and molecular docking of some substituted pyrazolines and isoxazolines as potential antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cytochrome P-450 Enzyme System; Fluconazole; Fungi; Isoxazoles; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Docking Simulation; Pyrazoles; Structure-Activity Relationship | 2015 |
Design and biological evaluation of novel quinolone-based metronidazole derivatives as potent Cu(2+) mediated DNA-targeting antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Chemistry Techniques, Synthetic; Ciprofloxacin; Copper; DNA, Bacterial; Drug Evaluation, Preclinical; Fibroblasts; Fluoroquinolones; HEK293 Cells; Humans; Metronidazole; Mice; Microbial Sensitivity Tests; Molecular Targeted Therapy; Norfloxacin; Pseudomonas aeruginosa; Quinolones; Structure-Activity Relationship | 2015 |
Synthesis of novel coumarin appended bis(formylpyrazole) derivatives: Studies on their antimicrobial and antioxidant activities.
Topics: Anti-Infective Agents; Antioxidants; Bacteria; Bacterial Infections; Coumarins; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrazoles; Quantitative Structure-Activity Relationship | 2016 |
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
Topics: Acrolein; Amino Acids; Anti-Infective Agents; Aspergillus niger; Escherichia coli; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Conformation; Penicillium; Schiff Bases; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Structure-Activity Relationship | 2016 |
Discovery of membrane active benzimidazole quinolones-based topoisomerase inhibitors as potential DNA-binding antimicrobial agents.
Topics: Anti-Bacterial Agents; Benzimidazoles; Binding Sites; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Discovery; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Quinolones; Structure-Activity Relationship; Topoisomerase Inhibitors | 2016 |
Synthesis of newer 1,2,3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Cell Line, Tumor; Chalcone; Dose-Response Relationship, Drug; Flavones; Fungi; Humans; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Triazoles | 2016 |
Novel amalgamation of phthalazine-quinolines as biofilm inhibitors: One-pot synthesis, biological evaluation and in silico ADME prediction with favorable metabolic fate.
Topics: Anti-Infective Agents; Biofilms; Candida albicans; Candidiasis; Computer Simulation; Humans; Phthalazines; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines | 2016 |
Novel benzimidazol-2-ylidene carbene precursors and their silver(I) complexes: Potential antimicrobial agents.
Topics: Anti-Infective Agents; Benzimidazoles; Candida; Enterococcus faecalis; Escherichia coli; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Silver; Spectrum Analysis; Staphylococcus aureus | 2016 |
Methylsulfonyl benzothiazoles (MSBT) derivatives: Search for new potential antimicrobial and anticancer agents.
Topics: Anti-Infective Agents; Antineoplastic Agents; Bacteria; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Fungi; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure | 2017 |
Synthesis of 1,3,5-trisubstituted pyrazolines as potential antimalarial and antimicrobial agents.
Topics: Anti-Infective Agents; Antimalarials; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Pyrazoles; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared | 2017 |
New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies.
Topics: Anti-Infective Agents; Antifungal Agents; Azoles; Candida; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Fungal Proteins; Humans; Models, Molecular; Molecular Docking Simulation; Monocytes; Structure-Activity Relationship | 2017 |
Novel quinoxalinyl chalcone hybrid scaffolds as enoyl ACP reductase inhibitors: Synthesis, molecular docking and biological evaluation.
Topics: Anti-Infective Agents; Antineoplastic Agents; Binding Sites; Candida albicans; Cell Proliferation; Chalcones; Disk Diffusion Antimicrobial Tests; Drug Design; Enoyl-CoA Hydratase; Enzyme Inhibitors; Escherichia coli; Humans; MCF-7 Cells; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Structure, Tertiary; Staphylococcus aureus | 2017 |
Discovery of a Membrane-Active, Ring-Modified Histidine Containing Ultrashort Amphiphilic Peptide That Exhibits Potent Inhibition of Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Membrane; Chlorocebus aethiops; Cryptococcus neoformans; DNA Damage; Drug Stability; Fluconazole; Hemolysis; Humans; Methicillin-Resistant Staphylococcus aureus; Oligopeptides; Structure-Activity Relationship; Surface-Active Agents; Swine; Vero Cells | 2017 |
Combating Drug-Resistant Fungi with Novel Imperfectly Amphipathic Palindromic Peptides.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Cytoplasm; Drug Resistance, Fungal; HEK293 Cells; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Intracellular Membranes; Inverted Repeat Sequences; Mice; Models, Molecular; Peptides; Protein Conformation; RAW 264.7 Cells | 2018 |
Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Bacillus cereus; Dose-Response Relationship, Drug; Free Radicals; Hydrogen Bonding; Microbial Sensitivity Tests; Molecular Structure; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
Synthesis, crystal structure and antimicrobial potential of some fluorinated chalcone-1,2,3-triazole conjugates.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Bacillus subtilis; Candida albicans; Chalcone; Crystallography, X-Ray; Dose-Response Relationship, Drug; Escherichia coli; Halogenation; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pseudomonas aeruginosa; Staphylococcus epidermidis; Structure-Activity Relationship; Triazoles | 2018 |
Design, synthesis, molecular-docking and antimycobacterial evaluation of some novel 1,2,3-triazolyl xanthenones.
Topics: | 2017 |
Synthesis, biological evaluations and computational studies of N-(3-(-2-(7-Chloroquinolin-2-yl)vinyl) benzylidene)anilines as fungal biofilm inhibitors.
Topics: Aniline Compounds; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Biofilms; Candida albicans; Microbial Sensitivity Tests; Quinolines; Structure-Activity Relationship | 2019 |
Efficient click chemistry towards novel 1H-1,2,3-triazole-tethered 4H-chromene-d-glucose conjugates: Design, synthesis and evaluation of in vitro antibacterial, MRSA and antifungal activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzopyrans; Click Chemistry; Drug Design; Fungi; Glucose; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Triazoles | 2019 |
Design, synthesis and biological evaluation of novel α-acyloxy carboxamides via Passerini reaction as caspase 3/7 activators.
Topics: Amides; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Candida albicans; Caspase 3; Caspase 7; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Design; Drug Screening Assays, Antitumor; Enterococcus faecalis; Escherichia coli; Fibroblasts; Humans; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship | 2019 |
Anthraquinone-Based Specialized Metabolites from Rhizomes of
Topics: Anthraquinones; Anti-Bacterial Agents; Antifungal Agents; Asphodelaceae; Microbial Sensitivity Tests; Molecular Structure; Rhizome; Spectrum Analysis | 2019 |
4-Substituted picolinohydrazonamides as a new class of potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Bacteria; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Thiosemicarbazones; Yeasts | 2020 |
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
Topics: Animals; Antifungal Agents; Antitubercular Agents; Aspergillus niger; Bacterial Proteins; Drug Design; Gram-Negative Bacteria; Isoniazid; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Protein Binding; RAW 264.7 Cells; Triazoles | 2020 |
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles | 2020 |
Synthesis and biological screening of thiosemicarbazones of substituted 3-acetylcoumarins having d-glucose moiety.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Coumarins; Fungi; Glucose; Humans; Microbial Sensitivity Tests; Mycoses; Structure-Activity Relationship; Thiosemicarbazones | 2020 |
Microwave assisted regioselective synthesis of quinoline appended triazoles as potent anti-tubercular and antifungal agents via copper (I) catalyzed cycloaddition.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus; Candida albicans; Catalysis; Cell Survival; Copper; Cycloaddition Reaction; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Quinolines; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2021 |
Pyrimidine-conjugated fluoroquinolones as new potential broad-spectrum antibacterial agents.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pyrimidines | 2022 |
Prevention of infection during neutropenia.
Topics: Ciprofloxacin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fluconazole; Humans; Male; Middle Aged; Neutropenia | 1992 |
Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient.
Topics: Anuria; Candidiasis; Ciprofloxacin; Cyclosporine; Fluconazole; Hemofiltration; Humans; Liver Transplantation; Male; Middle Aged; Vancomycin | 1995 |
Experience in treating secondary systemic mycotic infection after severe burns associated with electric injury.
Topics: Adult; Amputation, Surgical; Burns, Electric; Candidiasis; Ciprofloxacin; Fluconazole; Humans; Male; Peptic Ulcer Hemorrhage; Pseudomonas Infections; Renal Insufficiency | 1995 |
Bacterial infection in a patient with onychomycosis.
Topics: Anti-Infective Agents; Antifungal Agents; Ciprofloxacin; Fluconazole; Humans; Male; Middle Aged; Nail Diseases; Onychomycosis; Pseudomonas Infections | 1997 |
Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Antifungal Agents; Candidiasis; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Fluconazole; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Naphthyridines; Topoisomerase II Inhibitors | 1997 |
Clonal expansion of Staphylococcus epidermidis strains causing Hickman catheter-related infections in a hemato-oncologic department.
Topics: Air Microbiology; Antibiotic Prophylaxis; Bacteriological Techniques; Catheterization, Central Venous; Catheters, Indwelling; Ciprofloxacin; Fluconazole; Genotype; Hematologic Neoplasms; Humans; Mycoses; Neutropenia; Random Amplified Polymorphic DNA Technique; Restriction Mapping; Skin; Staphylococcal Infections; Staphylococcus epidermidis | 1998 |
Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Female; Fluconazole; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Penicillins; Streptococcal Infections; Streptococcus; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
Mediastinitis and retropharyngeal abscess following delayed diagnosis of glass ingestion.
Topics: Anti-Infective Agents; Antifungal Agents; Candidiasis; Ciprofloxacin; Diagnostic Errors; Escherichia coli Infections; Female; Fluconazole; Foreign Bodies; Glass; Humans; Infant; Mediastinitis; Pharynx; Retropharyngeal Abscess; Tomography, X-Ray Computed | 2006 |
Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Ciprofloxacin; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Logistic Models; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors | 2010 |
[37-year old patient with fever, diarrhea and lymphadenopathy].
Topics: Adult; AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Fever of Unknown Origin; Fluconazole; Giardia lamblia; Giardiasis; HIV Seropositivity; HIV-1; Homosexuality, Male; Humans; Immunoblotting; Lymphatic Diseases; Male; Metronidazole; Omeprazole | 2010 |
[Ochrobactrum anthropi and polymicrobial peritonitis in peritoneal dialysis: a resistance predictor].
Topics: Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluconazole; Glomerulonephritis, IGA; Gram-Negative Bacterial Infections; Humans; Imipenem; Middle Aged; Ochrobactrum anthropi; Peritoneal Dialysis; Peritonitis; Pseudomonas Infections | 2010 |
Synthesis, antimicrobial and antimycobacterial evaluation of [2-(substituted phenyl)-imidazol-1-yl]-pyridin-3-yl-methanones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Ciprofloxacin; Fluconazole; Imidazoles; Ketones; Microbial Sensitivity Tests; Molecular Structure; Pyridines | 2011 |
Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained.
Topics: Abdominal Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Exudates and Transudates; Female; Fluconazole; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Suction; Treatment Outcome; Vancomycin | 2011 |
The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience.
Topics: Acyclovir; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Chemoprevention; Ciprofloxacin; Escherichia coli; Female; Fever of Unknown Origin; Fluconazole; Humans; Immunocompromised Host; Incidence; Male; Middle Aged; Staphylococcus aureus; Stem Cell Transplantation; Treatment Outcome; Young Adult | 2012 |
A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution.
Topics: Administration, Oral; Bariatric Surgery; Biological Availability; Chemistry, Pharmaceutical; Ciprofloxacin; Computer Simulation; Cytochrome P-450 CYP3A; Diclofenac; Fluconazole; Humans; Intestinal Mucosa; Models, Biological; Obesity, Morbid; Omeprazole; Permeability; Pharmaceutical Preparations; Simvastatin; Solubility | 2012 |
Wide intra- and inter-country variability in drug use and dosage in very-low-birth-weight newborns with severe infections.
Topics: Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Utilization; Europe; Fluconazole; Health Care Surveys; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Practice Guidelines as Topic; Practice Patterns, Physicians'; Sepsis | 2013 |
The use of ciprofloxacin and fluconazole in Italian neonatal intensive care units: a nationwide survey.
Topics: Anti-Infective Agents; Antifungal Agents; Ciprofloxacin; Drug Utilization; Fluconazole; Health Care Surveys; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Italy; Practice Guidelines as Topic; Practice Patterns, Physicians'; Sepsis | 2013 |
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Bacteremia; Candidiasis; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Enterococcus; Female; Fluconazole; Fungemia; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Multivariate Analysis; Neutropenia; Retrospective Studies; Risk Factors; Staphylococcal Infections; Streptococcal Infections; Time Factors; Transplantation, Homologous; Viridans Streptococci; Young Adult | 2014 |
Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Bacteremia; Candida albicans; Candidiasis; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Ciprofloxacin; Developing Countries; Escherichia coli; Escherichia coli Infections; Febrile Neutropenia; Female; Fluconazole; Fungemia; Fusariosis; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pakistan; Retrospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Valacyclovir; Valine; Virus Diseases; Young Adult | 2014 |
[In vivo evaluation of the metabolic ratio of CYP2C9 and CYP1A2 drug markers after administration of afobazole in comparison to standard inducers and inhibitors of cytochromes].
Topics: Animals; Anti-Anxiety Agents; Anti-Bacterial Agents; Anticonvulsants; Antifungal Agents; Benzimidazoles; Ciprofloxacin; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Cytochromes; Enzyme Induction; Enzyme Inhibitors; Fluconazole; Male; Morpholines; Phenytoin; Rats; Rifampin | 2013 |
Epidemiology of antimicrobial resistance in an oncology center in eastern India.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts | 2015 |
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin | 2015 |
Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia.
Topics: Acute Disease; Acyclovir; Amphotericin B; Antifungal Agents; Appendicitis; Aspergillosis; Aspergillus; Child; Ciprofloxacin; Fluconazole; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Voriconazole | 2016 |
Unusual course of microsporidial keratoconjunctivitis as an occupational hazard in a veterinary physician.
Topics: Adult; Animals; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Humans; Keratoconjunctivitis; Microscopy, Fluorescence; Microsporidia; Microsporidiosis; Occupational Diseases; Ointments; Ophthalmic Solutions; Veterinarians; Zoonoses | 2016 |
Synergistic activity of doped zinc oxide nanoparticles with antibiotics: ciprofloxacin, ampicillin, fluconazole and amphotericin B against pathogenic microorganisms.
Topics: Amphotericin B; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Fluconazole; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nanoparticles; Zinc Oxide | 2016 |
Opioid Dependent Malingerer with Self-Induced Sepsis.
Topics: Analgesics, Opioid; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Echinocandins; Emergency Service, Hospital; Female; Fluconazole; Humans; Lipopeptides; Malingering; Micafungin; Opioid-Related Disorders; Sepsis; Staphylococcal Infections; Young Adult | 2016 |
Implications of Antimicrobial Combinations in Complex Wound Biofilms Containing Fungi.
Topics: Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida albicans; Ciprofloxacin; Diabetic Foot; Floxacillin; Fluconazole; Foot Ulcer; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 2017 |
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software.
Topics: Ciprofloxacin; Clarithromycin; Computer Simulation; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Fluconazole; Humans; Itraconazole; Ketoconazole; Models, Biological; Paroxetine; Quinidine; Rifampin; Software | 2018 |
QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors.
Topics: Ciprofloxacin; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Monitoring, Physiologic; Prevalence; Prospective Studies; Risk Factors | 2018 |
Synthesis and in vitro evaluation of 2-(((2-ether)amino)methylene)-dimedone derivatives as potential antimicrobial agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Ciprofloxacin; Cyclohexanones; Dose-Response Relationship, Drug; Ether; Fluconazole; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure | 2018 |
A rare case of scleral buckle infection with Curvularia species.
Topics: Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Ciprofloxacin; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Humans; Male; Middle Aged; Mycoses; Prosthesis-Related Infections; Scleral Buckling | 2018 |
Disseminated
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Cryptococcosis; Cryptococcus neoformans; Extracorporeal Membrane Oxygenation; Fluconazole; Flucytosine; Heart-Assist Devices; Humans; Immunocompetence; Intra-Aortic Balloon Pumping; Male; Middle Aged; Shock, Septic; ST Elevation Myocardial Infarction | 2019 |
Antibiotic-Based Conjugates Containing Antimicrobial HLopt2 Peptide: Design, Synthesis, Antimicrobial and Cytotoxic Activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Ciprofloxacin; Drug Stability; Escherichia coli; Fluconazole; HEK293 Cells; Hep G2 Cells; Humans; Immunoconjugates; Lactoferrin; Levofloxacin; Male; Microbial Sensitivity Tests; Peptide Fragments; Staphylococcus aureus; Swine | 2019 |
Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Azoles; Carbapenems; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Doripenem; Drug Monitoring; Female; Fluconazole; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Linezolid; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazines; Oxazolidinones; Quinolones; Tandem Mass Spectrometry; Tetrazoles; Voriconazole | 2021 |
Quality of Active Pharmaceutical Ingredients Present on Algerian Soil: Control of Impurities of Ciprofloxacin, Metronidazole and Fluconazole.
Topics: Algeria; Ciprofloxacin; Drug Contamination; Fluconazole; Metronidazole; Pharmaceutical Preparations; Soil | 2022 |
Impact of narrowing perioperative antibiotic prophylaxis for left ventricular assist device implantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ciprofloxacin; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Retrospective Studies; Rifampin; Treatment Outcome; Vancomycin | 2022 |
Exposure of anti-infective drugs and the dynamic changes of the gut microbiota during gastrointestinal mucositis in autologous stem cell transplant patients: a pilot study.
Topics: Anti-Infective Agents; Ciprofloxacin; Citrulline; Fluconazole; Follow-Up Studies; Gastrointestinal Microbiome; Humans; Middle Aged; Mucositis; Pilot Projects; Prospective Studies; Stem Cell Transplantation | 2023 |
Oral antimicrobial agents in patients with short bowel syndrome: worth a try!
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Female; Floxacillin; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Short Bowel Syndrome | 2023 |